// App-Quantinova.ai

: CO-1: A Novel Bifunctional CD47 Antibody for the Treatment of Hematologic Malignancies

Researchers

Presenter

  • Sittana Matar

Principal Investigators

  • Seham Skah

  • Rolf D Pettersen

  • Kjetil Hestdal

  • Nina Richartz

Medical Centers

  • University of Stavanger, Stavanger, Norway

  • ShareLab, Oslo Science Park, Caedo Oncology, Oslo, Norway

  • Insitute of Basic Medical Sciences/ Department of Molecular Medicine, University of Oslo, Oslo, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • Red Blood Cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved